MedRx Co., Ltd (TYO:4586)

MedRx Ratios and Metrics

Market cap in millions JPY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 8, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,005	3,882	5,793	2,665	3,148	3,949
Market Cap Growth	76.14%	-32.98%	117.37%	-15.34%	-20.28%	-4.59%
Enterprise Value	5,257	1,550	3,927	1,572	1,389	2,572
Last Close Price	118.00	82.00	151.00	95.00	128.00	211.00
Forward PE	-	8.82	8.82	8.82	8.82	8.82
PS Ratio	58.38	15.11	199.76	45.17	393.52	34.34
PB Ratio	3.26	1.79	3.01	2.20	1.61	1.84
P/TBV Ratio	3.26	1.79	3.01	2.20	1.61	1.84
EV/Sales Ratio	43.81	6.03	135.42	26.65	173.65	22.36
Debt / Equity Ratio	-	-	-	-	-	0.02
Asset Turnover	0.05	0.12	0.02	0.03	0.00	0.05
Inventory Turnover	0.06	-	0.33	0.32	0.13	0.22
Quick Ratio	30.07	19.25	17.71	6.39	13.81	15.16
Current Ratio	31.19	19.73	18.03	6.88	14.03	15.46
Return on Equity (ROE)	-52.62%	-39.40%	-59.48%	-70.18%	-51.63%	-54.78%
Return on Assets (ROA)	-29.38%	-22.91%	-33.84%	-39.25%	-30.11%	-31.54%
Return on Capital (ROIC)	-30.32%	-24.23%	-37.25%	-43.47%	-31.94%	-33.28%
Return on Capital Employed (ROCE)	-53.80%	-36.50%	-47.80%	-88.80%	-53.50%	-50.40%
Earnings Yield	-17.92%	-20.76%	-16.09%	-41.69%	-33.64%	-28.21%
FCF Yield	-	-20.68%	-15.76%	-40.30%	-29.38%	-25.93%
Buyback Yield / Dilution	-23.10%	-24.99%	-37.12%	-18.76%	-31.47%	-35.01%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.